Fenebrutinib (GDC-0853)
CAS: 1434048-34-6
Ref. 3D-JHC04834
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Informação sobre produto
Fenebrutinib is a long-acting monoclonal antibody that inhibits the activity of stem cell factor. It binds to the stem cell factor, preventing it from binding to its receptor and causing platelets to aggregate. Fenebrutinib has been shown to be safe and effective in preclinical studies for heparin-induced thrombocytopenia and related conditions, including autoimmune diseases such as rheumatoid arthritis. Fenebrutinib is being developed as a treatment for cancer, inflammatory bowel disease, and other autoimmune disorders. This drug is selective for c-KIT (a type of enzyme called kinase) but does not affect other kinases such as JAK1 or JAK2.
Propriedades químicas
Consulta técnica sobre: 3D-JHC04834 Fenebrutinib (GDC-0853)
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
